| Genome scale metabolic models as tools for drug design and personalized medicine V Raškevičius, V Mikalayeva, I Antanavičiūtė, I Ceslevičienė, ... PloS one 13 (1), e0190636, 2018 | 59 | 2018 |
| A metabolic modeling approach reveals promising therapeutic targets and antiviral drugs to combat COVID-19 F Santos-Beneit, V Raškevičius, VA Skeberdis, S Bordel Scientific reports 11 (1), 11982, 2021 | 37 | 2021 |
| The effect of nutmeg essential oil constituents on Novikoff hepatoma cell viability and communication through Cx43 gap junctions R Mickus, G Jančiukė, V Raškevičius, V Mikalayeva, I Matulytė, M Marksa, ... Biomedicine & Pharmacotherapy 135, 111229, 2021 | 16 | 2021 |
| Synthesis and antiproliferative activity of α-branched α, β-unsaturated ketones in human hematological and solid cancer cell lines I Karpavičienė, G Valiulienė, V Raškevičius, I Lebedytė, A Brukštus, ... European Journal of Medicinal Chemistry 98, 30-48, 2015 | 12 | 2015 |
| Molecular basis for potentiation of Cx36 gap junction channel conductance by n-alcohols and general anesthetics V Raškevičius, V Jotautis, L Rimkutė, A Marandykina, M Kazokaitė, ... Bioscience reports 38 (1), BSR20171323, 2018 | 10 | 2018 |
| Comparison of performance of docking, LIE, metadynamics and QSAR in predicting binding affinity of benzenesulfonamides V Raškevišius, V Kairys Current Computer-Aided Drug Design 11 (3), 237-244, 2015 | 4 | 2015 |
| Predicting Isoform-specific binding selectivities of benzensulfonamides using QSAR and 3D-QSAR V Raskevicius, V Kairys Current Computer-Aided Drug Design 13 (1), 75-83, 2017 | 3 | 2017 |
| Evaluation of Cx43 Gap Junction Inhibitors Using a Quantitative Structure-Activity Relationship Model R Matusevičiūtė, E Ignatavičiūtė, R Mickus, S Bordel, VA Skeberdis, ... Biomedicines 11 (7), 1972, 2023 | 1 | 2023 |
| A Novel chemical compound inhibits BCAT2 in cancer cells M Pankevičiūtė, V Mikalayeva, V Raškevičius, I Sarapinienė FEBS Open Bio: Supplement: 45th FEBS Congress, Molecules of Life: Towards …, 2021 | 1 | 2021 |
| Impact of CYP2C19 Gene Variants on Long-Term Treatment with Atorvastatin in Patients with Acute Coronary Syndromes D Čereškevičius, V Zabiela, A Aldujeli, V Lesauskaitė, K Zubielienė, ... International Journal of Molecular Sciences 25 (10), 5385, 2024 | | 2024 |
| Phosphorylation-dependent allosteric regulation of Cx43 gap junction inhibitor potency R Mickus, V Raškevičius, I Sarapinienė, V Mikalayeva, R Prekeris, ... Biomedicine & Pharmacotherapy 174, 116550, 2024 | | 2024 |
| Impact of genetic variation on lipid lowering therapy with atorvastatinin patients with CAD D Čereškevičius, K Zubielienė, A Aldujeli, V Raškevičius, V Tatarūnas Health for All: 2023-International Conference Health for All “Rare diseases …, 2023 | | 2023 |
| Connexin Type-and Protein Kinase-Specific Modulation of Gap Junction Inhibitor Potency by Phosphorylation/Raškevičius Vytautas, Mickus Rokas, Skeberdis Vytenis Arvydas V Raškevičius, R Mickus, VA Skeberdis International Gap Junction Conference (IGJC 2022): A Coruña, Spain, July 16 …, 2022 | | 2022 |
| Phosphorylation-Dependent Regulation of CX43 Gap Junction Inhibitor Potency R Mickus, V Raškevičius, V Mikalayeva, I Sarapinienė, VA Skeberdis International Gap Junction Conference (IGJC 2022): A Coruña, Spain, July 16 …, 2022 | | 2022 |
| Terpenes are Potent Cx43 Gap R Mickus, V Raškevičius, I Matulytė, M Marksa, K Maciūnas, ... 3rd Baltic Biophysics Conference: abstract book: 2022 October 6-7th, Vilnius …, 2022 | | 2022 |
| Integral actin facilitates connexin-43 hemichannel docking between daughter cells V Raškevičius, R Mickus, M Valius, I Sarapinienė, VA Skeberdis 3rd Baltic Biophysics Conference: abstract book: 2022 October 6-7th, Vilnius …, 2022 | | 2022 |
| Phosphorylation of Cx43 by Ca²⁺/calmodulin kinase II increases the sensitivity of Cx43 gap junction channels to chemical gating VA Skeberdis, R Mickus, V Raškevičius 3rd Baltic Biophysics Conference: abstract book: 2022 October 6-7th, Vilnius …, 2022 | | 2022 |
| Assessment of the inhibitors of connexins-43 using Quantitative structure-activity relationship (QSAR) model R Matusevičiūtė, E Ignatavičiūtė, V Raškevičius, VA Skeberdis IHS [International Health Sciences] Conference [6th]: abstract book:[Kaunas …, 2022 | | 2022 |
| Inhibition of valine degradation pathway affects cancer cell viability/G. Jančiukė, V. Mikalayeva, I. Sarapinienė, V. Raškevičius, VA Skeberdis, S. Bordel Velasco G Jančiukė, V Mikalayeva, I Sarapinienė, V Raškevičius, VA Skeberdis, ... FEBS Open Bio: Supplement: 45th FEBS Congress, Molecules of Life: Towards …, 2021 | | 2021 |
| Baltymų kinazių įtaka plyšinių jungčių jautrumui farmakologinėmis medžiagomis= Regulation of gap junction chemical gating by protein kinases R Mickus, V Raškevičius, G Jančiukė, VA Skeberdis 44-oji Lietuvos nacionalinė fizikos konferencija: 2021 m. spalio 6-8 d …, 2021 | | 2021 |
Visvaldas KairysVilnius UniversityEmail verificata su bti.vu.lt
